Correlation Between Forte Biosciences and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Forte Biosciences and SAB Biotherapeutics, you can compare the effects of market volatilities on Forte Biosciences and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and SAB Biotherapeutics.
Diversification Opportunities for Forte Biosciences and SAB Biotherapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Forte and SAB is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Forte Biosciences and SAB Biotherapeutics
Given the investment horizon of 90 days Forte Biosciences is expected to generate 84.04 times less return on investment than SAB Biotherapeutics. But when comparing it to its historical volatility, Forte Biosciences is 14.65 times less risky than SAB Biotherapeutics. It trades about 0.02 of its potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 6.91 in SAB Biotherapeutics on August 30, 2024 and sell it today you would lose (0.08) from holding SAB Biotherapeutics or give up 1.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 75.35% |
| Values | Daily Returns |
Forte Biosciences vs. SAB Biotherapeutics
Performance |
| Timeline |
| Forte Biosciences |
| SAB Biotherapeutics |
Forte Biosciences and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Forte Biosciences and SAB Biotherapeutics
The main advantage of trading using opposite Forte Biosciences and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Forte Biosciences vs. Indaptus Therapeutics | Forte Biosciences vs. Rezolute | Forte Biosciences vs. Tempest Therapeutics | Forte Biosciences vs. ABVC Biopharma |
| SAB Biotherapeutics vs. SAB Biotherapeutics | SAB Biotherapeutics vs. Jasper Therapeutics | SAB Biotherapeutics vs. NRx Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |